Dysphagia in Neurofibromatosis Type 1 Patients

Pathophysiology and Clinical Presentation

Plexiform neurofibromas in the head and neck region are the primary structural cause of dysphagia in NF1 patients, affecting the swallowing mechanism and leading to significant morbidity and mortality risks from aspiration and malnutrition 1
These neurofibromas have a predilection to cause spontaneous bleeding, potentially worsening dysphagia symptoms 2
NF1 can affect the central swallowing network or downstream peripheral nerves that coordinate the complex sensorimotor task of swallowing, leading to impairments in planning, coordination, and timing of swallowing 3, 4
NF1-associated vasculopathy may contribute to neurogenic dysphagia through cerebrovascular complications, affecting 0.4-6.4% of patients 1, 2

Unrecognized and untreated dysphagia in NF1 patients can lead to serious complications, including aspiration pneumonia, which significantly increases mortality risk 3, 4
Reduced quality of life and insufficient medication intake are potential consequences of dysphagia in NF1 patients 4
Nutritional assessment and intervention are crucial to prevent malnutrition and dehydration in NF1 patients with dysphagia 3, 4

A detailed history focusing on specific symptoms of oropharyngeal dysphagia is essential for clinical evaluation of NF1 patients 5
Age-related changes in swallowing physiology may compound existing dysphagia issues in older NF1 patients 4, 5
NF1-associated tumors are age-dependent, with different manifestations occurring at different life stages 6